Open AccessPB2132: COPANLISIB PLUS RITUXIMAB‐BENDAMUSTINE FOR RELAPSED‐REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LINFOMI (FIL_COPA‐RB)
Author(s) -
Novo M.,
Castellino A.,
Chiappella A.,
Ciccone G.,
Balzarotti M.,
Arcari A.,
Scarpa E.,
Tucci A.,
Di Renzo N.,
Tarantini G.,
Gini G.,
Moretti M.,
Mannina D.,
Di Rocco A.,
Spina M.,
Vitolo U.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000851360.15794.a8
Subject(s) - bendamustine , medicine , rituximab , oncology , diffuse large b cell lymphoma , phases of clinical research , refractory (planetary science) , lymphoma , clinical trial , surgery , biology , astrobiology